In vitro assessment shows guanidine derivative's antimicrobial and α-amylase inhibition, suggesting potential for drug development.
GHC shows broad-spectrum antimicrobial activity and measurable α-amylase inhibition, warranting further optimization to improve efficacy and pharmacokinetics.
No takes yet. Share an insight, caveat, or question.
Ahamed et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: